ArticlePsychopharmacology2026
Fentanyl decreases arterial blood oxygen saturation more than furanylfentanyl in mice due to increased apnea.
Article in Psychopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
11 authors.
Funding
Abstract
rationaleFatal opioid overdoses involving synthetic opioids have increased >10-fold over the past 8 years. Fentanyl, a potent synthetic opioid acting at the mu-opioid receptor (MOR), has largely replaced heroin as the predominant illicit opioid available. Various analogs have been synthesized from the fentanyl scaffold, including 2-furanylfentanyl, one of the most trafficked analogs from 2019 to 2024. Despite its prevalence, the in vivo effects of furanylfentanyl are not well characterized, especially regarding respiratory depression.
objectivesTo characterize furanylfentanyl relative to fentanyl in vitro and compare the effects of both drugs in mouse models of antinociception and respiratory depression.
methodsThe affinity and potency of fentanyl and furanylfentanyl were determined in CHO cells overexpressing MOR. Male and female CD-1 mice were administered (i.p.) fentanyl or furanylfentanyl prior to measuring antinociception (warm-water tail withdrawal), respiration (whole-body plethysmography), or oxygen saturation (pulse oximetry).
resultsFuranylfentanyl behaves as a partial agonist in vitro relative to fentanyl and morphine but with similar affinity and potency at MOR. In mice, fentanyl and furanylfentanyl produced similar effects on breathing parameters (including rate and inspiration time) that were greater than those induced by morphine, yet only fentanyl caused a drastic, long-lasting depletion of blood oxygen saturation. The discrepancy between effects on breathing and oxygen saturation may be explained by a greater number of apneas induced by fentanyl.
conclusionsThese results highlight the complexity of fentanyl-induced respiratory depression and indicate that recreational use of 2-furanylfentanyl in humans may pose a greater risk of overdose than morphine but lesser than fentanyl.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.